Skip to main content

Table 1

From: Baseline characteristics of patients with and without hypercoaguable sepsis and the effect of afelimomab on mortality: a post hoc analysis from the MONARCS trial

  

Absence of

 

Hypercoaguable

hypercoaguable

 

state

state

 

(n = 594)

(n = 719)

Mean age (SD)

57.9 (17.0)

60.1 (17.0)

Gender (M/F)

58.6% / 41.4%

61.6% / 38.4%

Shock

399 (67.2%)

504 (70.1%)

MOD score

9.1

6.3

Median interleukin-6 (pg/ml)

1360

908

Mean platelet count × 1000 (SD)

81.7 (35.6)

231.4 (141.7)

Positive blood culture (%)

278 (46.8%)

226 (31.4%)

G (+) bacteria only (%)

185 (31.1%)

207 (28.8%)

G (–) bacteria only (%)

169 (28.5%)

177 (24.6%)

Mixed G (+) and G (–) (%)

65 (10.9%)

102 (14.2%)

Other or unknown (%)

175 (29.5%)

233 (32.4%)

Back to article page

Critical Care

ISSN: 1364-8535